Impact of High-flow Nasal Oxygen During Awake Fiberoptic Bronchoscope Guided Intubation: A Retrospective Study

August 25, 2021 updated by: Yonsei University
Retrospective data collection. The aim of this study is to investigate impact of high-flow nasal oxygen on safety(lowest oxygen saturation), efficiency (intubation time, need for multiple attempts) in patients underwent awake fiberoptic bronchoscope guided intubation.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of
        • Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who underwent awake fiberoptic bronchoscope guided intubation for surgery

Description

Inclusion Criteria:

1.Patients who underwent awake fiberoptic bronchoscope guided intubation for surgery

Exclusion Criteria:

  1. Cases in which other procedures (e.g. arterial line cannulation) were performed prior to endotracheal intubation after entering operation room
  2. Patients with Incomplete records of oxygen saturation, attempt number, and time taken for awake intubation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intra-procedural lowest saturation
Time Frame: Intra-procedural lowest saturation
Intra-procedural lowest saturation: lowest oxygen saturation on pulse oximetry during awake intubation
Intra-procedural lowest saturation
need for multiple attempts
Time Frame: Intra-procedural (need for multiple attempts : during awake intubation)
need for multiple attempts : more than 2 attempts needed during awake intubation
Intra-procedural (need for multiple attempts : during awake intubation)
time taken for awake intubation
Time Frame: Intra-procedural (Time taken for awake intubation: time from entering the operating room to completion of awake endotracheal intubation)
Time taken for awake intubation: time from entering the operating room to completion of awake endotracheal intubation
Intra-procedural (Time taken for awake intubation: time from entering the operating room to completion of awake endotracheal intubation)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

September 1, 2021

Primary Completion (ANTICIPATED)

October 1, 2021

Study Completion (ANTICIPATED)

October 1, 2021

Study Registration Dates

First Submitted

August 24, 2021

First Submitted That Met QC Criteria

August 25, 2021

First Posted (ACTUAL)

August 26, 2021

Study Record Updates

Last Update Posted (ACTUAL)

August 26, 2021

Last Update Submitted That Met QC Criteria

August 25, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 4-2021-0901

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Awake Fiberoptic Bronchoscope Guided Intubation

Subscribe